Genomic Testing Cooperative, LCA
Lake Forest, CA Genomic Testing Cooperative
- UEI
- NMAYSL9NW6M9
- CAGE
- 87PF1
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 621511 Medical Laboratories Primary
- SAM.gov registration date
- Physical address
- 25371 Commercentre Dr, Lake Forest, CA 92630, USA
- Website
- genomictestingcooperative.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nhlbi: service: next generation sequencing: severable | Office of Logisitics and Acquisition Operations | $216,000 | |
| The purpose of this purchase order is to supply nhlbi with next generation sequencing. | Office of Logisitics and Acquisition Operations | $24,000 | |
| [26-002822] nhlbi DR young lab members requires hematology panel: sequencing somatic mutations in bone marrow samples.… | National Heart Lung and Blood Institute | $24,000 | |
| [26-000910] the lab requires hematology panel - sequencing somatic mutations in bone marrow samples in order to take… | National Heart Lung and Blood Institute | $24,000 | |
| [25-013882] DR young lab members requires hematology panel: sequencing somatic mutations in bone marrow samples in order… | National Heart Lung and Blood Institute | $24,000 |
About Genomic Testing Cooperative, LCA
Genomic Testing Cooperative, LCA Genomic Testing Cooperative Division is a self-certified small disadvantaged business based in Lake Forest, California that provides next-generation sequencing (NGS) and hematology panel testing services exclusively to the National Heart, Lung and Blood Institute (NHLBI) as a prime contractor on firm fixed-price purchase orders. The firm operates entirely in the unset-aside commercial market, competing on capability and pricing rather than set-aside reserve.
The vendor's capability footprint is narrow and specialized. Genomic Testing Cooperative delivers 177-gene hematology panel sequencing on bone marrow samples to detect somatic mutations associated with blood disorders, hematologic malignancies, and bone marrow failure syndromes. The work supports NHLBI's Young Lab biomedical research and diagnostic initiatives, with turnaround time of ten calendar days from specimen receipt through final analysis and reporting. The contractor maintains CLIA certification, performs automated DNA and RNA extraction, and provides secure electronic reporting with authenticated access controls. Representative awards include a $216 thousand ceiling purchase order (June 2026) for ongoing NGS testing of bone marrow samples with a one-year performance window; a $114 thousand order (November 2022) for next-generation sequencing on 177 genes; and a $90 thousand order (December 2023) for detection of somatic gene mutations in patients. The source notes the firm has received contracts totaling over $650 thousand since 2021 and describes capabilities in tumor profiling and cancer biomarker analysis including DNA and RNA testing.
Customer concentration is absolute and singular. All twenty-six awards and 100% of combined potential value ($1.3 million) fund NHLBI programs. The vendor has no identified subcontractor relationships and operates entirely as a prime. Activity has grown modestly — three awards in 2022, one in 2023, four in 2024, six in 2025, and three in 2026 year-to-date — with six awards (combined potential value $336 thousand) reaching ultimate completion inside the next twenty-four months. Award velocity remains low relative to baseline potential value, suggesting either limited utilization against established capacity or a narrow scope of work within NHLBI's larger testing portfolio.
Quick answers
What is Genomic Testing Cooperative, LCA's UEI?
Genomic Testing Cooperative, LCA's Unique Entity ID (UEI) in SAM.gov is NMAYSL9NW6M9.
What is Genomic Testing Cooperative, LCA's CAGE code?
Genomic Testing Cooperative, LCA's CAGE code is 87PF1.
What is Genomic Testing Cooperative, LCA's primary NAICS code?
Genomic Testing Cooperative, LCA's primary NAICS code is 621511 (Medical Laboratories).
Where is Genomic Testing Cooperative, LCA located?
Genomic Testing Cooperative, LCA's physical address in SAM.gov is 25371 Commercentre Dr, Lake Forest, CA 92630, USA.
Is Genomic Testing Cooperative, LCA registered in SAM.gov?
Yes. Genomic Testing Cooperative, LCA's SAM.gov registration is active through December 16, 2026.
What is Genomic Testing Cooperative, LCA's most recent federal award?
Genomic Testing Cooperative, LCA's most recent federal contract award is Nhlbi: service: next generation sequencing: severable (75N98026P00650), from Office of Logisitics and Acquisition Operations, on June 5, 2026.
On GovTribe
See Genomic Testing Cooperative, LCA's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors